It is also important to mention that adverse effects (such as anemia) of antibodies, including those targeting TfR1, may be triggered by the effector functions of the Fc region such as ADCC and/or complement-mediated cytotoxicity (CDC) [16,51]. The gene discussed is TFRC; the disease is anemia (phenotype).